Search research articles
Contact Us
Filters
Showing results (191-200 of 298) with videos related to
Page
of 30
Sort By:
Brain : a Journal of Neurology
|
November 16, 2022
Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates
Morgane Darricau, Taxiarchis Katsinelos, Flavio Raschella, et al.
Journal of the American Society for Mass Spectrometry
|
April 13, 2023
On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI-MS Imaging
Ibrahim Kaya, Luke S Schembri, Anna Nilsson, et al.
Communications Biology
|
September 23, 2021
Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson's disease and L-Dopa induced dyskinesia
Lauren Malave, Dustin R Zuelke, Santiago Uribe-Cano, et al.
Neurobiology of Disease
|
January 14, 2020
Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy
Heather Hulme, Elva Fridjonsdottir, Halla Gunnarsdottir, et al.
Frontiers in Aging Neuroscience
|
October 14, 2014
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?
Giselle Charron, Evelyne Doudnikoff, Marie-Helene Canron, et al.
Vaccines
|
September 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice
Sabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, et al.
Neurobiology of Disease
|
March 15, 2006
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine
Wassilios Meissner, Paula Ravenscroft, René Reese, et al.
Annals of Neurology
|
October 26, 2018
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
Alberto J Espay, Francesca Morgante, Aristide Merola, et al.
Experimental Neurology
|
October 19, 2006
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease
Dieter Scheller, Piu Chan, Qin Li, et al.
Brain : a Journal of Neurology
|
October 28, 2008
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
Ana Muñoz, Qin Li, Fabrizio Gardoni, et al.
Page
of 30
Search research articles
Search
Showing results (191-200 of 298) with videos related to
Sort By:
Page
of 30
Brain : a Journal of Neurology
|
November 16, 2022
Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates
Morgane Darricau, Taxiarchis Katsinelos, Flavio Raschella, et al.
Journal of the American Society for Mass Spectrometry
|
April 13, 2023
On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI-MS Imaging
Ibrahim Kaya, Luke S Schembri, Anna Nilsson, et al.
Communications Biology
|
September 23, 2021
Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson's disease and L-Dopa induced dyskinesia
Lauren Malave, Dustin R Zuelke, Santiago Uribe-Cano, et al.
Neurobiology of Disease
|
January 14, 2020
Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy
Heather Hulme, Elva Fridjonsdottir, Halla Gunnarsdottir, et al.
Frontiers in Aging Neuroscience
|
October 14, 2014
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?
Giselle Charron, Evelyne Doudnikoff, Marie-Helene Canron, et al.
Vaccines
|
September 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice
Sabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, et al.
Neurobiology of Disease
|
March 15, 2006
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine
Wassilios Meissner, Paula Ravenscroft, René Reese, et al.
Annals of Neurology
|
October 26, 2018
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
Alberto J Espay, Francesca Morgante, Aristide Merola, et al.
Experimental Neurology
|
October 19, 2006
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease
Dieter Scheller, Piu Chan, Qin Li, et al.
Brain : a Journal of Neurology
|
October 28, 2008
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
Ana Muñoz, Qin Li, Fabrizio Gardoni, et al.
Page
of 30